Gastroenterology Research and Practice This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Monitoring a Mandatory Nonmedical Switching Policy from Originator to Biosimilar Infliximab in Patients with Inflammatory Bowel Diseases: A Population-Based Cohort Study
CONCLUSION: British Columbia's Biosimilars Initiative for nonmedical switching from originator to biosimilar infliximab for inflammatory bowel diseases was not associated with harmful impacts on medications and health services use. An increase in dose escalation was accompanied by an improvement in health status proxies.PMID:36911254 | PMC:PMC9995207 | DOI:10.1155/2023/2794220 (Source: Gastroenterology Research and Practice)
Source: Gastroenterology Research and Practice - March 13, 2023 Category: Gastroenterology Authors: Anat Fisher Jason D Kim Colin R Dormuth Source Type: research

Comparison between Submucosal Tunneling Endoscopic Resection and Endoscopic Submucosal Dissection for Prepyloric Submucosal Tumors: A Case-Matched Controlled Study
CONCLUSIONS: For the treatment of prepyloric SMTs, P-STER appeared to be a more effective endoscopic technique compared with ESD, although further randomized controlled trials were warranted.PMID:36911253 | PMC:PMC9995185 | DOI:10.1155/2023/5931360 (Source: Gastroenterology Research and Practice)
Source: Gastroenterology Research and Practice - March 13, 2023 Category: Gastroenterology Authors: Wengang Zhang Jiafeng Wang Ningli Chai Enqiang Linghu Source Type: research

Monitoring a Mandatory Nonmedical Switching Policy from Originator to Biosimilar Infliximab in Patients with Inflammatory Bowel Diseases: A Population-Based Cohort Study
CONCLUSION: British Columbia's Biosimilars Initiative for nonmedical switching from originator to biosimilar infliximab for inflammatory bowel diseases was not associated with harmful impacts on medications and health services use. An increase in dose escalation was accompanied by an improvement in health status proxies.PMID:36911254 | PMC:PMC9995207 | DOI:10.1155/2023/2794220 (Source: Gastroenterology Research and Practice)
Source: Gastroenterology Research and Practice - March 13, 2023 Category: Gastroenterology Authors: Anat Fisher Jason D Kim Colin R Dormuth Source Type: research

Comparison between Submucosal Tunneling Endoscopic Resection and Endoscopic Submucosal Dissection for Prepyloric Submucosal Tumors: A Case-Matched Controlled Study
CONCLUSIONS: For the treatment of prepyloric SMTs, P-STER appeared to be a more effective endoscopic technique compared with ESD, although further randomized controlled trials were warranted.PMID:36911253 | PMC:PMC9995185 | DOI:10.1155/2023/5931360 (Source: Gastroenterology Research and Practice)
Source: Gastroenterology Research and Practice - March 13, 2023 Category: Gastroenterology Authors: Wengang Zhang Jiafeng Wang Ningli Chai Enqiang Linghu Source Type: research

Monitoring a Mandatory Nonmedical Switching Policy from Originator to Biosimilar Infliximab in Patients with Inflammatory Bowel Diseases: A Population-Based Cohort Study
CONCLUSION: British Columbia's Biosimilars Initiative for nonmedical switching from originator to biosimilar infliximab for inflammatory bowel diseases was not associated with harmful impacts on medications and health services use. An increase in dose escalation was accompanied by an improvement in health status proxies.PMID:36911254 | PMC:PMC9995207 | DOI:10.1155/2023/2794220 (Source: Gastroenterology Research and Practice)
Source: Gastroenterology Research and Practice - March 13, 2023 Category: Gastroenterology Authors: Anat Fisher Jason D Kim Colin R Dormuth Source Type: research